Found 14 matching trials
A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases. PHASE2 This study will evaluate the efficacy and safety data of AZD8871 in patient...
Show More Learn More & Join Trial
Description of the Ability to Learn How to Handle Inhaler Devices in Asthma NA Asthma is a major public health problem. The main treatments against asthma...
Show More Location
Bordeaux University Hospital
Learn More & Join Trial
Effect of Vilanterol on Methacholine Challenge Results PHASE4 The study will assess the degree of bronchoprotection provided by the ultra...
Show More Location
Asthma Research Lab - University of Saskatchewan
Learn More & Join Trial
Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) NA The purpose of this study is to compare in COPD patients naïve to DPIs, the...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma PHASE2 This study is conducted to evaluate the effects of UMEC 62.5 microgram (mcg...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents PHASE4 Exercise induced asthma (EIA) is common in adolescents. (Fluticasone furoat...
Show More Location
Rambam Medical Center
Learn More & Join Trial
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. PHASE3 The purpose of this study is to demonstrate that the efficacy of the combin...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices PHASE4 The purpose of this study was to compare dynamic inspiratory flow rates ach...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects PHASE4 Chronic obstructive pulmonary disease (COPD) is a preventable and treatable...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease PHASE4 This is a randomized, multi-centre, open-label, placebo-device, cross-over ...
Show More Location
GSK Investigational Site
Learn More & Join Trial